動物保健市場：商業機會、成長要素、產業趨勢分析及2026-2035年預測

2025年全球動物保健市場價值為2,208億美元，預計2035年將以5.9%的複合年成長率成長至3,994億美元。

市場成長的驅動力在於動物疾病發生率的上升，包括需要高級獸醫護理的慢性病和感染疾病。農業環境、住宅環境和城市生態系統中人與動物接觸的增加也凸顯了有效動物健康管理的重要性。動物保健市場涵蓋了廣泛的全球產業，專注於預防、診斷和治療影響伴侶動物和牲畜健康的疾病。這包括動物用藥品、疫苗、診斷解決方案、藥用飼料添加劑、醫療設備和一次性用品，旨在保護動物健康並支持畜牧業生產力。此外，加強疾病控制有助於降低通用感染疾病的風險，進而保護公眾健康。該行業正逐步從一般治療方法轉向更先進的預防性和針對性的醫療保健解決方案。雖然伴侶動物生技藥品和特化單株抗體的應用日益增多，但畜牧業醫療保健也越來越依賴尖端疫苗技術和基於畜群的疾病預防策略。此外，隨著診斷技術和基於生物標記的檢測手段日益普及，個人化獸醫學正受到越來越多的關注，使獸醫能夠根據動物的物種特徵和具體健康狀況量身定做治療方案。同時，以患者為中心的治療方案的開發也拓展了傳統藥物治療以外的治療可能性。

預計到2025年，獸醫服務市佔率將達到74.5%，並在2035年之前以6%的複合年成長率成長。這一強勁的市場趨勢主要受可支配收入成長和對專業獸醫護理需求增加的驅動。人們對動物健康和福利的日益關注，促使更多人為寵物尋求全面的獸醫服務。此外，獸醫技術的進步也擴大了該領域的服務範圍。更多寵物專屬服務變得更加便捷，從而提高了獸醫機構的使用率。現代醫療保健技術的整合以及服務交付的改進，正在增強整個獸醫服務行業的整體實力，並支持市場的持續擴張。

預計到2025年，伴侶動物市場規模將達到1,331億美元。該市場包含伴侶動物群體中的多個子群體。全球飼養寵物作為伴侶的趨勢日益成長，是推動該市場成長的主要動力。如今，世界各地許多家庭都飼養寵物作為伴侶，這導致對獸醫護理、醫療產品和專業醫療保健服務的需求不斷增加。寵物健康和保健支出的增加也推動了創新動物保健解決方案的開發和應用。此外，新興經濟體可支配收入的成長使更多寵物飼主能夠投資於先進的醫療保健產品和獸醫服務，從而進一步促進了伴侶動物市場的擴張。

預計到2025年，北美動物保健市佔率將達到38.5%。該地區憑藉其完善的獸醫基礎設施和先進的動物醫療解決方案的廣泛應用，保持著主導地位。創新療法、疫苗和寄生蟲控制產品在伴侶動物和家畜中的積極應用，推動了該地區市場的成長。北美也受益於先進診斷技術和精準獸醫方法的早期應用。擁有強大研發能力的關鍵產業參與者的存在，進一步加速了該地區的創新。人們對預防性動物保健意識的不斷提高，以及對影響動物的慢性疾病和通用感染疾病日益成長的關注，持續推動對先進獸醫服務和優質動物保健產品的需求。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章業界考察

• 生態系分析
• 影響產業的因素
  • 促進因素
    • 寵物數量增加
    • 政府和民眾加大對動物照護的支持度
    • 對線上動物用藥品局的需求日益成長
    • 動物醫療保健支出增加
  • 產業潛在風險與挑戰
    • 動物用藥品高成本
    • 遍遠地區的通行限制
  • 市場機遇
    • 遠端醫療和遠距獸醫諮詢的擴展
    • 擴大以預防和保健為重點的動物保健解決方案的普及應用。
• 成長潛力分析
• 技術趨勢（基於初步調查）
  • 當前技術趨勢
  • 新興技術
• 監理情勢（基於初步調查）
• 還款方案（基於初步調查）
• 動物用藥品產業創業投資趨勢
• 動物用藥品產業的經濟影響
• 消費行為趨勢（基於初步調查）
• 未來市場趨勢（基於初步研究）
• 人工智慧和生成式人工智慧對市場的影響
• 波特五力分析
• PESTEL 分析

第4章 競爭情勢

• 介紹
• 企業市佔率分析
• 企業矩陣分析
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 主要進展
  • 併購
  • 夥伴關係與合作
  • 新產品發布
  • 業務拓展計劃

第5章 市場估價與預測：依產品分類，2022-2035年

• 製藥
  • 種類
    • 製藥
      • 殺蟲劑
      • 消炎（藥）
      • 抗感染藥物
      • 皮質類固醇
      • 鎮靜劑
      • 循環系統藥物
      • 消化器官系統藥物
      • 其他藥物
    • 疫苗
      • 減毒活病毒疫苗（MLV）
      • 去活化疫苗
      • 其他疫苗
    • 藥用飼料添加劑
      • 抗生素
      • 維他命
      • 胺基酸
      • 酵素
      • 抗氧化劑
      • 益生元和益生菌
      • 礦物
      • 其他藥用飼料添加劑
  • 適應症
    • 皮膚科
    • 循環系統疾病
    • 消化系統疾病
    • 呼吸系統疾病
    • 其他跡象
  • 銷售管道
    • 獸藥
    • 電子商務
    • 零售藥房
• 醫療設備
  • 獸醫診斷設備
  • 麻醉設備
  • 病患監測設備
  • 獸用外科器械
  • 動物用品
  • 其他醫療設備
• 獸醫醫療服務

第6章 市場估計與預測：依動物種類分類，2022-2035年

• 伴侶動物
  • 狗
  • 貓
  • 馬
  • 其他伴侶動物
• 家畜
  • 家禽
  • 豬
  • 牛
  • 魚
  • 其他牲畜

第7章 市場估計與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 海灣合作理事會國家
  • 以色列

第8章：公司簡介

• B. Braun Vet Care（B Braun Melsungen）
• Boehringer Ingelheim
• Ceva Sante Animale
• Dechra Pharmaceuticals
• Elanco Animal Health
• Endovac Animal Health
• HIPRA
• IDEXX Laboratories
• Merck
• Medtronic
• Neogen
• Sklar Surgical Instruments
• Symrise
• Vetoquinol
• Virbac
• Zoetis
• Phibro Animal Health
• Indian Immunologicals
• Kyoritsu Seiyaku
• Ourofino Saude Animal

The Global Animal Healthcare Market was valued at USD 220.8 billion in 2025 and is estimated to grow at a CAGR of 5.9% to reach USD 399.4 billion by 2035.

Market growth is influenced by the increasing occurrence of animal diseases, including both long-term health conditions and infectious illnesses that require advanced veterinary care. The rising interaction between humans and animals across agricultural settings, residential environments, and urban ecosystems has also elevated the importance of effective animal health management. The animal healthcare market encompasses a broad global industry dedicated to preventing, diagnosing, and treating medical conditions affecting both companion animals and livestock populations. It includes veterinary pharmaceuticals, vaccines, diagnostic solutions, medicated feed additives, medical equipment, and disposable supplies designed to protect animal health and support livestock productivity. In addition, improved disease control helps safeguard public health by reducing the risk of zoonotic disease transmission. The industry is gradually shifting away from generalized treatment methods toward more advanced preventive and targeted healthcare solutions. Increased adoption of biologics and specialized monoclonal antibodies for companion animals is becoming more common, while livestock healthcare is increasingly supported by modern vaccine technologies and herd-level disease prevention strategies. Personalized veterinary medicine is also gaining traction as diagnostic capabilities and biomarker-based testing become more widely available, allowing veterinarians to customize treatments based on species characteristics and specific health conditions. Furthermore, the development of patient-friendly therapeutic options is expanding treatment possibilities beyond conventional medication methods.

The veterinary services segment held a 74.5% share in 2025 and is projected to grow at a CAGR of 6% throughout 2035. This strong market performance is largely driven by increasing disposable income levels and rising demand for professional veterinary care. Growing awareness about animal health and well-being has encouraged more individuals to seek comprehensive veterinary services for their animals. In addition, advancements in veterinary medical technologies have expanded the scope of services available within the sector. A wide range of pet-focused services has become more accessible, supporting higher utilization of veterinary facilities. The integration of modern healthcare technologies and improved service offerings is strengthening the overall veterinary services segment and supporting continued market expansion.

The companion animals segment generated USD 133.1 billion in 2025. This segment is categorized into several groups within the broader companion animal population. Rising global adoption of animals as household companions is a major factor supporting the growth of this segment. A significant portion of households worldwide currently care for animals as companions, contributing to increased demand for veterinary care, medical products, and specialized healthcare services. Higher spending on pet health and wellness is also encouraging the development and introduction of innovative animal healthcare solutions. In addition, growing disposable income levels in emerging economies are enabling more pet owners to invest in advanced healthcare products and veterinary services, further supporting the expansion of the companion animals segment.

North America Animal Healthcare Market held a 38.5% share in 2025. The region maintains a leading position due to its well-established veterinary healthcare infrastructure and widespread adoption of advanced medical solutions for animal care. Strong utilization of innovative therapeutics, vaccines, and parasite control products across both companion animal and livestock populations contributes to regional market growth. North America also benefits from the early implementation of advanced diagnostic technologies and precision veterinary healthcare approaches. The presence of major industry participants with strong research and development capabilities further accelerates innovation within the region. Growing awareness of preventive animal healthcare, along with increasing concern regarding chronic and zoonotic diseases affecting animals, continues to drive demand for advanced veterinary services and premium animal health products.

Key companies operating in the Global Animal Healthcare Market include Zoetis, Merck, Boehringer Ingelheim, Elanco Animal Health, Virbac, Vetoquinol, Ceva Sante Animale, Dechra Pharmaceuticals, IDEXX Laboratories, Phibro Animal Health, Neogen, HIPRA, B. Braun Vet Care (B Braun Melsungen), Symrise, Sklar Surgical Instruments, Medtronic, Endovac Animal Health, Indian Immunologicals, Kyoritsu Seiyaku, and Ourofino Saude Animal. Companies active in the Animal Healthcare Market are implementing several strategic approaches to strengthen their competitive position and expand their global footprint. A key focus area is investment in research and development aimed at introducing innovative veterinary pharmaceuticals, vaccines, and diagnostic technologies. Many organizations are also expanding their product portfolios through strategic partnerships, acquisitions, and collaborations with biotechnology firms and veterinary research institutions. Geographic expansion into emerging markets is another important strategy, as companies seek to capture rising demand for animal health products in developing regions. In addition, firms are enhancing digital capabilities by integrating data-driven diagnostics, tele-veterinary services, and advanced monitoring technologies into their offerings. Companies are also prioritizing sustainable production practices and regulatory compliance to maintain product credibility while supporting long-term growth in the animal healthcare market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research approach
• 1.3 Quality commitments
  • 1.3.1 GMI AI policy and data integrity commitment
    • 1.3.1.1 Source consistency protocol
• 1.4 Research trail and confidence scoring
  • 1.4.1 Research trail components
  • 1.4.2 Scoring components
• 1.5 Data collection
  • 1.5.1 Partial list of primary sources
• 1.6 Data mining sources
  • 1.6.1 Paid sources
    • 1.6.1.1 Sources, by region
• 1.7 Base estimates and calculations
  • 1.7.1 Revenue share analysis
  • 1.7.2 Base year calculation
• 1.8 Forecast model
• 1.9 Research transparency addendum
  • 1.9.1 Source attribution framework
  • 1.9.2 Quality assurance metrics
  • 1.9.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Animal type trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing population of pet animals
    • 3.2.1.2 Increasing support offered by government and public organizations for animal care
    • 3.2.1.3 Growing demand for online veterinary pharmacies
    • 3.2.1.4 Increase in animal healthcare expenditure
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with animal health drugs
    • 3.2.2.2 Limited access in rural areas
  • 3.2.3 Market opportunities
    • 3.2.3.1 Expansion of telemedicine and remote veterinary consultation
    • 3.2.3.2 Rising adoption of preventive and wellness-focused animal health solutions
• 3.3 Growth potential analysis
• 3.4 Technology landscape (Driven by Primary Research)
  • 3.4.1 Current technological trends
  • 3.4.2 Emerging technologies
• 3.5 Regulatory landscape (Driven by Primary Research)
  • 3.5.1 North America
  • 3.5.2 Europe
  • 3.5.3 Asia Pacific
  • 3.5.4 Latin America
  • 3.5.5 Middle East and Africa
• 3.6 Reimbursement scenario (Driven by Primary Research)
• 3.7 Venture capitalist scenario in animal health industry
• 3.8 Economic impacts of the animal health industry
• 3.9 Consumer behaviour trends (Driven by Primary Research)
• 3.10 Future market trends (Driven by Primary Research)
• 3.11 Impact of AI and generative AI on the market
• 3.12 Porter's analysis
• 3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Merger and acquisition
  • 4.6.2 Partnership and collaboration
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Pharmaceuticals
  • 5.2.1 Type
    • 5.2.1.1 Drugs
      • 5.2.1.1.1 Antiparasitic
      • 5.2.1.1.2 Anti-inflammatory
      • 5.2.1.1.3 Anti-infectives
      • 5.2.1.1.4 Corticosteroids
      • 5.2.1.1.5 Tranquilizers
      • 5.2.1.1.6 Cardiovascular drugs
      • 5.2.1.1.7 Gastrointestinal drugs
      • 5.2.1.1.8 Other drugs
    • 5.2.1.2 Vaccines
      • 5.2.1.2.1 Modified live vaccines (MLV)
      • 5.2.1.2.2 Killed inactivated vaccines
      • 5.2.1.2.3 Other vaccines
    • 5.2.1.3 Medicated feed additives
      • 5.2.1.3.1 Antibiotics
      • 5.2.1.3.2 Vitamins
      • 5.2.1.3.3 Amino acids
      • 5.2.1.3.4 Enzymes
      • 5.2.1.3.5 Antioxidants
      • 5.2.1.3.6 Prebiotics and probiotics
      • 5.2.1.3.7 Minerals
      • 5.2.1.3.8 Other medicated feed additives
  • 5.2.2 Indication
    • 5.2.2.1 Dermatology
    • 5.2.2.2 Cardiovascular diseases
    • 5.2.2.3 Gastrointestinal diseases
    • 5.2.2.4 Respiratory diseases
    • 5.2.2.5 Other indications
  • 5.2.3 Distribution channel
    • 5.2.3.1 Veterinary hospital pharmacies
    • 5.2.3.2 E-commerce
    • 5.2.3.3 Retail pharmacies
• 5.3 Medical devices
  • 5.3.1 Veterinary diagnostic equipment
  • 5.3.2 Anesthesia equipment
  • 5.3.3 Patient monitoring equipment
  • 5.3.4 Veterinary surgical equipment
  • 5.3.5 Veterinary consumables
  • 5.3.6 Other medical devices
• 5.4 Veterinary services

Chapter 6 Market Estimates and Forecast, By Animal Type, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Companion animals
  • 6.2.1 Dogs
  • 6.2.2 Cats
  • 6.2.3 Horses
  • 6.2.4 Other companion animals
• 6.3 Livestock animals
  • 6.3.1 Poultry
  • 6.3.2 Swine
  • 6.3.3 Cattle
  • 6.3.4 Fish
  • 6.3.5 Other livestock animals

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 India
  • 7.4.3 Japan
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 GCC Countries
  • 7.6.3 Israel

Chapter 8 Company Profiles

• 8.1 B. Braun Vet Care (B Braun Melsungen)
• 8.2 Boehringer Ingelheim
• 8.3 Ceva Sante Animale
• 8.4 Dechra Pharmaceuticals
• 8.5 Elanco Animal Health
• 8.6 Endovac Animal Health
• 8.7 HIPRA
• 8.8 IDEXX Laboratories
• 8.9 Merck
• 8.10 Medtronic
• 8.11 Neogen
• 8.12 Sklar Surgical Instruments
• 8.13 Symrise
• 8.14 Vetoquinol
• 8.15 Virbac
• 8.16 Zoetis
• 8.17 Phibro Animal Health
• 8.18 Indian Immunologicals
• 8.19 Kyoritsu Seiyaku
• 8.20 Ourofino Saude Animal